They never give you a straight answer about where they’re going, who they’re with, or what they’re doing. Every response is a ...

A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

his article will present eight dynamic crypto entrepreneurs and how they are defining this new era of digital empowerment and ...

A B Corps company, Chiesi’s LEED Platinum certified Biotech Centre of Excellence will focus mainly on rare disease biologics – another shift in the family-business pharma’s image and action.

The idea of invisibility has intrigued movie audiences and filmmakers for generations. It's not simply a superhero trait, but a doorway to storytelling that delves into what occurs when an individual ...

Researchers examined the addition of 3D total-body photography and sequential digital dermoscopy imaging to usual care on outcomes in patients at high risk for melanoma.

Researchers say a full-scale clinical trial of the therapy could help many patients with a particularly aggressive form of ...

For years, Dominari Holdings’ shifting priorities and tribulations remained largely out of the spotlight. That changed when ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Three-quarters of US-based researchers and graduate students are considering working abroad, according to a recent study.

ECF offers a unique blend of equities and convertible securities, delivering both capital appreciation and a high 6.6% yield ...